Functional genomic landscape of cancer-intrinsic evasion of killing by T cells

Keith A Lawson1,2,3, Cristovão M Sousa4, Xiaoyu Zhang1,2

  • 1Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.

Nature
|September 24, 2020
PubMed

Insights

Cancer cells evade immune attack through complex genetic pathways. This study identifies 182 key genes and highlights the roles of interferon response and autophagy in immune evasion, crucial for developing new cancer immunotherapies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Genetics

Background:

  • Cancer cells possess sophisticated genetic mechanisms to evade immune system detection and destruction.
  • Understanding these evasion strategies is critical for advancing cancer immunotherapy.

Purpose of the Study:

  • To identify a core set of genes and pathways enabling cancer cells to evade killing by cytotoxic T lymphocytes (CTLs).
  • To elucidate the coordinated genetic interactions governing immune evasion in cancer.

Main Methods:

  • Genome-wide CRISPR screens were conducted on diverse mouse cancer cell lines co-cultured with CTLs.
  • Genetic co-similarity analysis was employed to explore gene and pathway interactions.
  • In vivo CRISPR screens were integrated with cytokine and CTL genetic interaction mapping.

Main Results:

  • A core set of 182 genes was identified, where perturbation altered cancer cell sensitivity or resistance to CTL-mediated killing.
  • Dominant sub-phenotypes involved the interferon response and tumor necrosis factor (TNF)-induced cytotoxicity.
  • The autophagy pathway was confirmed as a conserved mediator of CTL evasion, crucial for resisting IFNγ and TNF-induced cytotoxicity.

Conclusions:

  • The study reveals key genetic circuits, including interferon response regulators and the autophagy pathway, that cancer cells utilize to evade CTLs.
  • These findings provide a deeper understanding of cancer immune evasion mechanisms and highlight potential therapeutic targets within the tumor microenvironment.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K